RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLNN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Clene Inc.
(Updated on Mar 28, 2024)

Sell candidate since Mar 25, 2024 Loss -1.07% PDF

The Clene Inc. stock price gained 0.0941% on the last trading day (Thursday, 28th Mar 2024), rising from $0.425 to $0.425. During the last trading day the stock fluctuated 2.50% from a day low at $0.420 to a day high of $0.431. The price has been going up and down for this period, and there has been a 1.29% gain for the last 2 weeks. Volume fell on the last day by -28 thousand shares and in total, 237 thousand shares were bought and sold for approximately $100.79 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.58% during the next 3 months and, with a 90% probability hold a price between $0.307 and $0.563 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLNN Signals & Forecast

There are mixed signals in the stock today. The Clene Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.426. On a fall, the stock will find some support from the short-term average at $0.425. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, January 25, 2024, and so far it has fallen -19.72%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Clene Inc. stock

Clene Inc. finds support from accumulated volume at $0.423 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0105 between high and low, or 2.50%. For the last week the stock has had daily average volatility of 5.71%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLNN) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Clene Inc. to open at $0.425, and during the day (based on 14 day Average True Range), to move between $0.389 and $0.462, which gives a possible trading interval of +/-$0.0367 (+/-8.63%) up or down from last closing price. If Clene Inc. takes out the full calculated possible swing range there will be an estimated 17.27% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.423 (0.56%) than the resistance at $0.430 (1.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Clene Inc. stock A Buy?

Clene Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.820 Sell Candidate Unchanged

Predicted Opening Price for Clene Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.425 ( 0.0235%) $0.425

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLNN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.436 2.44 %
R2 0.432 1.50 %
R1 0.429 0.92 %
Current price: 0.425
Support S1 0.421 -0.97 %
S2 0.419 -1.55 %
S3 0.415 -2.49 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.510 19.89 %
R2 0.500 17.54 %
R1 0.430 1.08 %
Current price 0.425
Support S1 0.423 -0.564%
S2 0.419 -1.50%
S3 0.354 -16.78%

FAQ

What is the symbol for Clene Inc. Stock and on which exchange is it traded?
The symbol for Clene Inc. is CLNN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Clene Inc. Stock?
Clene Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Clene Inc. Stock?
Clene Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Clene Inc. Stock.

What's the current price of Clene Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Clene Inc. (CLNN) share was $0.425.

What is the 52-week high and low for Clene Inc. Stock?
The 52-week high for Clene Inc. Stock is $1.22 and the 52-week low is $0.250.

What is the market capitalization of Clene Inc. Stock?
As of the 2024-03-28, the market capitalization of Clene Inc. is 54.634M.

When is the next earnings date for Clene Inc.?
The upcoming earnings date for Clene Inc. is May 10, 2024.
Click to get the best stock tips daily for free!

About Clene Inc.

Clene. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com... CLNN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT